Abstract
Background
Cardiogenic shock after acute myocardial infarction (AMI) remains a poor prognosis. Although numerous studies discussed the predictors of cardiogenic shock complicating AMI, the data in Chinese patients is still absent. The goal of this study is to develop a risk‐predictive score for cardiogenic shock after AMI, among Chinese patients, so as to guide clinicians to prevent cardiogenic shock.
Methods
Patients with ST‐segment elevated AMI were provided by two Chinese hospitals from 1994 to 2004. Baseline characteristics of each case were documented. Multivariable logistic regression modeling techniques were used to develop a model to predict the occurrence of cardiogenic shock within 72 h after admission. On the basis of the coefficients in the model, a risk score was developed for the probability of cardiogenic shock. To test its viability, another population, which was consistent with the original population, confirmed the scoring.
Results
Among 2,077 patients, 184 cases developed cardiogenic shock within 72 h. Age, gender, BMI, killip class, MI location, multivessel disease, previous MI, family history of CAD, and thrombolytic therapy were strong predictors for shock after AMI. A risk‐predictive score for shock was developed. It predicted cardiogenic shock accurately in another Chinese population.
Conclusions
A predictive model is developed in Chinese patients with AMI for the first time. It is based on some simple parameters, which can be easily obtained by clinicians. The risk score derived from the model can predict cardiogenic shock accurately. Copyright © 2007 Wiley Periodicals, Inc.
Keywords: cardiogenic shock; acute myocardial infarction; risk‐predictive score, Chinese
Full Text
The Full Text of this article is available as a PDF (280.9 KB).
REFERENCES
- 1. Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, et al: Contemporary reperfusion therapy for cardiogenic shock: The GUSTO‐1 Trail experience. J Am Coll Cardiol 1995; 26: 668–674. [DOI] [PubMed] [Google Scholar]
- 2. Holmes DR Jr, Hasdai D: Cardiogenic shock cimplicating non‐ST‐segment elevation acute coronary syndrome In Cardiogenic Shock: Diagnosis and Treatment. (Eds.Hasdai D, Berger PB, Batter A.), Totowa, New Jersey, NJ: Humana Press, 2002; pp 35–42. [Google Scholar]
- 3. Berger PB, Hasdai D. Cardiogenic shock complicating ST‐segment elevation acute coronary syndrome In Cardiogenic Shock: Diagnosis and Treatment. (Eds.Hasdai D, Berger PB, Batter A.), Totowa, New Jersey, NJ: Humana Press, 2002; pp 43–56. [Google Scholar]
- 4. Sutton AG, Finn P, Hall JA, Harcombe AA, Wright RA, et al: Predictors of outcome after percutaneous treatment for cardiogenic shock. Heart 2005; 91: 339–344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Katayama T, Nakashima H, Takagi C, Honda Y, Suzuki S, et al: Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock. Circ J 2005; 69: 83–88. [DOI] [PubMed] [Google Scholar]
- 6. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, et al: The arbeitsgemeinschaft leitende kardiologische krankenhausarzte (ALKK) Predictors of in‐hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 2004; 25: 322–328. [DOI] [PubMed] [Google Scholar]
- 7. Hasdai D, Califf RM, Thompson TD, Hochman JS, Ohman EM, et al: Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 2000; 35: 136–143. [DOI] [PubMed] [Google Scholar]
- 8. Hasdai D, Holmes DR Jr, Califf RM, Thompson TD, Hochman JS, et al: Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators Global utilization of streptokinase and tissue‐plasminogen activator for occluded coronary arteries. Am Heart J 1999; 138((1):Pt 1) 21–31. [DOI] [PubMed] [Google Scholar]
- 9. Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, et al: The MILIS Study Group The in‐hospital development of cardiogenic shock after myocardial infarction: Incidence, predictors of occurrence, outcome and prognostic factors. J Am Coll Cardiol 1989; 14:40–46 discussion 47–48. [DOI] [PubMed] [Google Scholar]
- 10. Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, et al: The in‐hospital development of cardiogenic shock after myocardial infarction: Incidence, predictors of occurrence, outcome and prognostic factors. J Am Coll Cardiol 1989; 14: 40–46. [DOI] [PubMed] [Google Scholar]
- 11. Lear J, Goldbrout U, Reicher‐Reiss H, Kaplinsky E, Behar S Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome. Am J Med 1993; 94: 265–273. [DOI] [PubMed] [Google Scholar]
- 12. Himbert D, Juliard JM, Steg G, Karrillon GJ, Aumont MC, et al: Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 1994; 74: 492–494. [DOI] [PubMed] [Google Scholar]
- 13. Walters MI, Burn S, Houghton T Cardiogenic shock: Are HEROICS justified? Circulation 1997; 96(suppl I): 168A. [Google Scholar]
- 14. Hasdai D, Harrington RA, Hochman JS, Califf RM, Battler A, et al: Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST‐segment elevation. J Am Coll Cardiol 2000; 36: 685–692. [DOI] [PubMed] [Google Scholar]
- 15. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673–682. [DOI] [PubMed] [Google Scholar]
- 16. LATE Study Group Late assessment of thrombolytic efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759–766. [PubMed] [Google Scholar]
- 17. FTT Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–322. [PubMed] [Google Scholar]
- 18. Lincoff AM, Topol EJ Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993; 88: 1361–1374. [DOI] [PubMed] [Google Scholar]